Macadamian Technologies inc.: federal grants and contributions: 9 agreements; $1.8M value; 2 departments; 4 programs.
Assay record ASY-CA-1JZYF5N1TJ · Cite as: Assay Systems, “Macadamian Technologies inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/macadamian-technologies-inc/
EUROSTARS project E!12835 X-AID with Radiobotics ApS (Denmark). X-AID will be a clinical decision support tool (CDST) to assist radiologists in providing a faster and more accurate description and diagnosis of routine X-ray images of bones and joints, leveraging fully automated algorithms. The consortium will apply novel machine learning (ML) techniques to develop a clinical decision support tool for musculoskeletal conditions, which will be fully integrated in Hospital Information Systems. Testing in clinical settings will validate performance, user acceptance and benefits of X-AID.
Developing new voice and data driven digital healthcare services that leverage the Firm's Hive platform to support patients with chronic disease and seniors at home while improving the effectiveness of the clinical teams supporting them.
BMWi AI 2020 - Project AIR_PTE - AI based Risk Prediction and Treatment Effect Estimation based on health claims data with German partner InGef. Macadamian is developing new digital health services that will leverage a predictive health analytics framework to support better patient outcomes leveraging historical healthcare data.
Macadamian intends to develop a scalable COVID-19 staff & resident screening solution that is deployed on a SaaS model in a day and which screens users for COVID-19 symptoms in less than 15 seconds to mitigate the spread of infection.
Macadamian a récemment lancé sa nouvelle offre de services appelée Macadamian HealthConnect. Le projet vise à accroître sa part de marché aux États-Unis et à la lancer en Europe.
The purpose of this CanExport Innovation grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.